What is known already: Growth in culture adversely impacts preimplantation embryo 22 development and alters the expression levels of the oxidative stress adaptor protein p66Shc, but 23 it is not known if p66Shc expression differences are linked to metabolic changes observed in 24 cultured embryos. 25
Study design, samples/materials, methods: We used a standard wild type CD1 mouse model of 26 preimplanation embryo development and embryo culture to modulate atmospheric oxygen 27 tension and glucose media concentrations. Changes to p66Shc expression in mouse blastocysts 28
were measured using RT-qPCR, immunoblotting, and immunofluorescence with confocal 29 microscopy. Changes to oxidative phosphorylation metabolism were measured by total ATP 30 content and superoxide production. Statistical analyses were performed on a minimum of three 31 experimental replicates using Students' t-test or one-way ANOVA. 32
Main results and the role of chance: P66Shc is basally expressed during in vivo mouse 33 preimplantation development. Within in vivo blastocysts, p66Shc is primarily localized to the 34 cell periphery of the trophectoderm. Blastocysts cultured under atmospheric oxygen levels have 35 significantly increased p66Shc transcript and protein abundances compared to in vivo controls (p 36 < 0.05). However, phosphorylated serine 36 (S36) p66Shc to total p66Shc ratio decreased under 37 culture regardless of O 2 atmosphere used, supporting a shift in the mitochondrial fraction of 38 p66Shc. Total p66Shc localized to the cell periphery of the blastocyst trophectoderm and 39 Glucose medium concentration did not significantly affect p66Shc expression or its localization. 42
Blastocysts cultured under low or high oxygen conditions exhibited significantly decreased 43 cellular ATP and increased superoxide production compared to in vivo derived embryos (p < 44
0.05). 45
Limitations, reasons for caution: This study associates embryonic p66Shc expression levels 46 with metabolic abnormalities but does not directly implicate p66Shc in metabolic changes. 47
Wider implications of the findings: This is the first study to show distinct immunolocalization 48 of p66Shc to the trophectoderm of blastocysts and that its levels are abnormally increased in 49 embryos exposed to culture conditions. Changes to p66Shc expression and/or localization could 50 serve as a molecular marker of embryo viability for clinical applications. The outcomes provide 51 insight into the potential metabolic role of p66Shc. Metabolic anomalies are induced even under 52 current best culture conditions, which could negatively impact trophectoderm and placental 53 development. 54 transfer may still not be the most developmentally competent. This is a particular concern in 75 current efforts to reduce multiple pregnancies by single embryo transfer (Grady et al., 2012) . 76
To further advance embryo culture and optimize culture parameters, it is important to 77 understand the biological mechanisms of the preimplantation embryo and its interactions with 78 the maternal and in vitro environment. Metabolism has emerged as an important research avenue 79 in efforts to understand how culture conditions affect the developmental competence of early 80 To define a new metabolic route in which preimplantation embryo culture may affect 98 early embryonic development, the objective of our study sought to determine if p66Shc 99 expression changes in cultured embryos compared to in vivo derived embryos, and if altered 100 p66Shc expression is a marker of altered embryo metabolism. In the following study, we use a 101 well-defined preimplantation mouse embryo culture model to modulate atmospheric conditions 102 (oxygen) and culture media (glucose concentration) to determine their effects on p66Shc 103 expression and readouts of oxidative phosphorylation metabolism. Our outcomes demonstrate 104 preimplantation developmental variations in p66Shc expression that are further exacerbated by 105 culture and correlate with aberrant mitochondrial ATP and ROS production. 
Materials and Methods

Embryo Collection and Culture 115
Three-to-four week old female mice were injected intraperitoneal with 7.5 IU pregnant 116 mare serum gonadotropin (Merck Animal Health, Canada) followed by injection of 7.5 IU 117 human chorionic gonadotropin (Merck Animal Health, Canada) 48 hours later. Female mice 118 were then placed with males for mating. Confirmation of mating was determined by checking for 119 the presence of a vaginal plug the next morning; presence of a vaginal plug indicated embryonic 120 day 0.5 (E0.5). Embryos were flushed with M2 medium (Sigma Aldrich, Canada) from the 121 oviducts and/or uteri of female mice according to the time post injection (hpi): zygotes (18 hpi), 122 2-cell embryos (44 hpi), 8-cell embryos (68 hpi) and blastocysts (90 hpi). Zygotes were briefly 123 incubated in M2 medium containing 1% hyaluronidase (Sigma Aldrich, Canada) to remove 124 cumulus cells. Embryos were washed twice in M2, then transferred to Extraction Buffer or 125 radioimmunoprecipitation assay buffer (RIPA buffer, 150 mM NaCl, 1% Triton X-100, 0.5% 126 sodium deoxycholate, 0.1% SDS, 50 mM Tris) until analysis, or to pre-equilibrated KSOMaa 127
Evolve medium supplemented with 1% bovine serum albumin (Zenith Biotech, USA). Embryos 128 were cultured under low (5% O 2 ) or high (in air) oxygen tensions in a 5% CO 2 , 37°C incubator. 129 Evolve to the desired concentration and embryos were cultured under low oxygen. For 131 transcriptional inhibition experiments, 10 mg/ml α-amanitin (Sigma Aldrich, Canada) in water 132 was diluted to 10 µg/ml in KSOMaa Evolve. 133
134
Real time RT-qPCR 135
Pools of twenty embryos collected from 1-3 mice were stored in Extraction Buffer (Life 136
Technologies, USA) at -80°C until use. Total RNA was extracted using the PicoPure RNA 137 isolation kit (Life Technologies, USA) according to the manufacturer's guidelines. For glucose 138 treatment experiments, 0.5 pg of exogenous luciferase mRNA (Promega, USA) was added to the 139 extract prior to ethanol precipitation. Eluted RNA was reverse transcribed to cDNA using 140 SuperScript III (Life Technologies, USA) according to manufacturer's instructions, with final 141 concentrations of 150 ng random hexamers (Life Technologies, USA) and 2 pmol p66Shc-142 specific reverse primer (Table I) . Real time qPCR was performed in a CFX384 thermocycler 143 (BioRad, Canada) with each reaction containing 7 µl PerfeCTa SYBR Green 2X SuperMix 144 (Quanta BioSciences, USA), 200 nM of forward and reverse primers (see Table I for all primer 145 sequences) and 4 µl cDNA (equivalent to 0.25 embryo per reaction). PCR conditions are as 146 follows: 95°C for 3 minutes, followed by 45 cycles of 95°C for 15 seconds, 59°C for 15 seconds, 147 and 72°C for 30 seconds. Relative transcript abundance was determined using the delta-delta CT 148 method using expression of Ppia and H2afz, or luciferase, for normalization (Mamo et al., 2007) . 149
To determine amplification specificity, PCR products after qPCR amplification of p66Shc in 150 blastocyst cDNA were purified using the PureLink Quick Gel Extraction and PCR Purification 151 Kit (Life Technologies, USA) according to manufacturer's instructions. PCR products were 152 
Blastocyst Cell Counts 214
Blastocysts were fixed in 4% paraformaldehyde in PBS, permeabilized in 0.2% Triton X-215 100 in PBS, and stained with DAPI for 1 hour at room temperature. Stained blastocysts were 216 imaged using laser scanning confocal microscopy, with three z-stacks taken per embryo. DAPI-217 positive nuclei from three stacks were counted using ImageJ. 218 transcript and protein were detectable in all stages observed. We observed a significant increase 235 in both transcript and protein abundance from the 8-cell to blastocyst stages ( Figure 1A , B). To 236 determine the cellular localization of p66Shc during preimplantation development, we performed 237 whole mount immunofluorescence followed by confocal microscopy using a p66Shc-specific 238 antibody on embryos from six developmental stages. We observed p66Shc immunoreactivity 239 throughout the cytoplasm of pre-compaction stage embryos ( These results indicate that p66Shc expression is normally upregulated in the blastocyst and may 245 be restricted primarily to the trophectoderm of in vivo produced blastocysts. 246 247
Statistical Analyses 220
Validation of NT-Shc antibody specificity 248
To verify that the antibodies used to detect p66Shc and phosphorylated (S36) p66Shc 249 only recognized the 66-kDa Shc isoform by immunofluorescence confocal microscopy, we 250 Under in vivo conditions, p66Shc expression levels may be fine-tuned to prevent adverse 263 developmental events. Given our observations within in vivo derived mouse embryos, we then 264 aimed to determine whether certain embryo culture conditions induce aberrant changes in 265 embryonic p66Shc expression levels. Mouse zygotes were cultured to three developmental stages 266 under low oxygen tension (5% O 2 ) or high oxygen tension (21% O 2 ). Real time RT-qPCR was 267 performed on pools of embryos to determine changes in p66Shc transcript abundance. 268
Blastocysts examined after 96 hours of culture showed increasing p66Shc transcript abundance 269 with increasing oxygen tension ( Figure 3A ). This increase was dependent on de novo 270 transcription of p66Shc, as the increase in p66Shc abundance was abolished in blastocysts 271 cultured at high oxygen tension in the presence of the transcriptional inhibitor α-amanitin 272 ( Figure 3B ). It is interesting to note that some p66Shc transcripts were still detectable in treated 273 Figure 3B ). Overall, these observations suggest that p66Shc is actively transcribed by the 275 embryo under atmospheric oxygen conditions. 276
We next aimed to determine if p66Shc protein abundance also increased under culture 277 and high oxygen. Immunoblotting for total p66Shc on pools of embryos showed a significant 278 increase in p66Shc protein abundance in cultured blastocysts ( Figure 4A ). This induction of 279 p66Shc expression was unique to the blastocyst stage, as p66Shc transcript abundance decreased 280 and protein abundance was unchanged in cultured 2-cell and 8-cell embryos (Supplemental 281 Figure 2A and B). We then saw that increasing oxygen tension significantly decreased the 282 phosphorylated S36 p66Shc to total p66Shc ratio in blastocysts, suggesting a possible change in 283 the mitochondrial fraction of p66Shc in cultured blastocysts ( Figure 4B ). Oxygen tension did not 284 alter the phosphorylated Y239/Y240 p66Shc to total p66Shc ratio ( Figure 4C ). These are two 285 residues on Shc1 proteins that are known to be phosphorylated after interaction with receptor 286 tyrosine kinases (Gotoh et al., 1997) . This result suggests that the shift in the 66-kDa band seen 287 in cultured blastocysts may be due to an alternative (e.g. Ser138, Y317) or novel post-288 translational modification induced by culture. 289
To determine if p66Shc cellular localization changed with embryo culture, cultured 290 blastocysts were stained for p66Shc immunoreactivity and were compared to freshly flushed, in 291 vivo derived blastocysts. Blastocysts cultured in high oxygen conditions showed an increase in 292 p66Shc fluorescence intensity and detectable diffuse p66Shc staining in putative ICM cells, 293 compared to in vivo and low oxygen cultured blastocysts ( Figure 5A-C) . To determine the 294 localization of phosphorylated S36 p66Shc, cultured blastocysts were stained for phosphorylated 295 S36 p66Shc immunoreactivity and compared to in vivo controls. Consistent with the 296 6A-C). In addition, phosphorylated S36 p66Shc was also detectable in inner cells of the in vivo 301 produced blastocyst while total p66Shc was not, indicating that there may be differences in 302 sensitivity between the two p66Shc antibodies (Figures 5A and 6A) . The localization pattern 303
suggests that the phosphorylated S36 p66Shc fraction in blastocysts produced in vivo or in 304 culture may be localized to a distinct compartment in the cytoplasm or nucleus compared to non-305 phosphorylated, or p66Shc phosphorylated at a different residue. 306
In addition to its role in mediating the oxidative stress response, several studies have 307 implicated p66Shc in regulating cellular glucose uptake through growth factor receptor signaling, control, suggesting that these embryos were not developing slower than the controls ( Figure 7C) . 320
To determine if p66Shc expression changed during culture in high glucose, we performed 321 RT-qPCR and immunoblotting for p66Shc in pools of blastocysts cultured in the four glucose 322 concentrations. Neither transcript levels nor protein abundance significantly changed in embryos 323 cultured in varying glucose conditions ( Figure 8A-B) , suggesting that p66Shc expression levels 324
are not sensitive to increased glucose in embryo culture media. To determine if p66Shc cellular 325 localization changed with glucose concentration, embryos cultured in 30 mM D-glucose were 326 stained for p66Shc immunoreactivity and compared to embryos cultured in KSOM. We saw 327 comparable peripheral and cytoplasmic p66Shc immunoreactivity in non-cavitated embryos after 328 high glucose culture compared to controls, suggesting that p66Shc cellular localization is not 329 impacted by media glucose concentrations ( Figure 8C) . 330
331
Changes to p66Shc expression in culture correlate with altered embryo metabolism 332
To determine if increased p66Shc expression levels in cultured embryos could be a 333 marker of altered embryo metabolism, we performed two metabolic assays on blastocysts 334 derived in vivo and after culture under low and high oxygen. We first assessed total ATP content 335 of blastocysts from each group, and observed that ATP levels per cell significantly decreased in 336 blastocysts cultured under low oxygen compared to in vivo blastocysts ( Figure 9A ). As oxidative 337 phosphorylation in the trophectoderm is the major source of cellular ATP in the blastocyst 338 (Houghton, 2006), we then assayed for production of superoxide in the same treatment groups. 339
Superoxide is a free radical produced as a by-product of oxidative phosphorylation that is 340 normally present at low levels and is readily scavenged by superoxide dismutase. Blastocysts 341 We observed that blastocysts cultured under low and high oxygen showed significantly higher 343
MitoSOX fluorescence compared to in vivo controls, suggesting increased superoxide production 344 or decreased antioxidant scavenging in these culture conditions ( Figure 9B 
changing media glucose concentrations did not significantly affect p66Shc expression levels in 359 the blastocyst. Lastly, we are the first to correlate these changes in culture and high oxygen 360 tension to dysregulated ATP and superoxide production within in vitro produced blastocysts. 361
Our expression analysis of p66Shc during in vivo blastocyst development suggests that 362 p66Shc is normally upregulated during the eight-cell embryo to blastocyst transition. This basal 363 level of expression during in vivo development implies that despite promoting apoptosis, p66Shc 364 expression maybe necessary for survival and prevent blastocysts from being selected against 365 
suggesting that p66Shc could be involved in trophectoderm metabolism. Although our study did 378 not directly test the role of p66Shc in oxidative phosphorylation, we have correlated increasing 379 p66Shc transcript and protein abundances after embryo culture with alterations to ATP and 380 superoxide production, suggesting that dysregulated p66Shc levels in the embryo may have a 381 negative impact on embryo metabolism. 382
Studies of p66Shc in mammalian embryos have thus far focused primarily on the 383
apoptosis-and senescence-promoting functions of p66Shc, basally or in stress-inducing culture 384 conditions. In bovine preimplantation embryos, siRNA-mediated knockdown of p66Shc reduces 385 levels of intracellular ROS, DNA damage, and apoptosis in untreated and oxidant-treated culture 386 conditions (Betts et al., 2014) . Bovine preimplantation embryos exhibit high levels of 387 developmental arrest (>50%) in culture (Leidenfrost et al., 2011), likely due to suboptimal 388 culture conditions, which could result in increased p66Shc transcript levels, leading to 389 senescence (permanent embryo arrest) and apoptosis. Due to species-specific differences in early 390 development, or better optimized conditions, mouse preimplantation embryos from inbred strains 391 exhibit high developmental rates with >75% of zygotes reaching the blastocyst stage in 392 The induction of p66Shc transcription in cultured blastocysts appears to be specific to 414 oxygen, as increasing media glucose concentrations did not significantly change p66Shc 415 transcript abundance compared to controls. Oxygen-sensitive induction in our results is 416 blastocysts. There is a significant increase in p66Shc mRNA abundance in blastocysts cultured at 621 high oxygen tension compared to in vivo controls (n=4, mean ± SEM, p=0.0305 1W-ANOVA). 622 (B) Blastocysts cultured for 24h in 10 µg/ml α-amanitin showed significantly decreased p66Shc 623 transcript abundance compared to controls (n=3, mean ± SEM, p=0.0477 Student's t-test). 624 
